INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 102 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $484,958 | -1.0% | 9,310 | +20.3% | 0.02% | +5.6% |
| Q2 2023 | $489,970 | +26.0% | 7,738 | +7.7% | 0.02% | +20.0% |
| Q1 2023 | $388,959 | +11.6% | 7,183 | 0.0% | 0.02% | +7.1% |
| Q4 2022 | $348,591 | +4.4% | 7,183 | 0.0% | 0.01% | -6.7% |
| Q3 2022 | $334,000 | -14.8% | 7,183 | +4.5% | 0.02% | -11.8% |
| Q2 2022 | $392,000 | +3.7% | 6,871 | +11.4% | 0.02% | +21.4% |
| Q1 2022 | $378,000 | +29.5% | 6,170 | +10.8% | 0.01% | +40.0% |
| Q4 2021 | $292,000 | +40.4% | 5,570 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $208,000 | -8.4% | 5,570 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $227,000 | +20.1% | 5,570 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $189,000 | +6.8% | 5,570 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $177,000 | +23.8% | 5,570 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $143,000 | +21.2% | 5,570 | +21.4% | 0.01% | 0.0% |
| Q2 2020 | $118,000 | +66.2% | 4,589 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $71,000 | -44.5% | 4,589 | +22.7% | 0.00% | -33.3% |
| Q4 2019 | $128,000 | +357.1% | 3,739 | 0.0% | 0.01% | +500.0% |
| Q3 2019 | $28,000 | -42.9% | 3,739 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $49,000 | +6.5% | 3,739 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $46,000 | +7.0% | 3,739 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $43,000 | -46.9% | 3,739 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $81,000 | +9.5% | 3,739 | -10.7% | 0.00% | 0.0% |
| Q2 2018 | $74,000 | -3.9% | 4,189 | +14.1% | 0.00% | 0.0% |
| Q1 2018 | $77,000 | +45.3% | 3,672 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $53,000 | -1.9% | 3,672 | +23.9% | 0.00% | -33.3% |
| Q3 2017 | $54,000 | +45.9% | 2,964 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $37,000 | -22.9% | 2,964 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $48,000 | – | 2,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |